NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

肺/呼吸藥物交付市場(2020-2030年):產品,製劑,設備,霧化器,罐類型,應用,分銷渠道,最終用戶,區域,主要公司的預測以及COVID-19回收方案

Pulmonary/Respiratory Drug Delivery Market Report 2020-2030: Forecasts by Product, Formulation, Devices, Nebulizers, Canister Type, Application, Distribution Channel, End-user, Region, Leading Companies, plus COVID-19 Recovery Scenarios

出版商 Visiongain Ltd 商品編碼 977833
出版日期 內容資訊 英文 487 Pages
商品交期: 最快1-2個工作天內
價格
肺/呼吸藥物交付市場(2020-2030年):產品,製劑,設備,霧化器,罐類型,應用,分銷渠道,最終用戶,區域,主要公司的預測以及COVID-19回收方案 Pulmonary/Respiratory Drug Delivery Market Report 2020-2030: Forecasts by Product, Formulation, Devices, Nebulizers, Canister Type, Application, Distribution Channel, End-user, Region, Leading Companies, plus COVID-19 Recovery Scenarios
出版日期: 2020年09月30日內容資訊: 英文 487 Pages
簡介

對抗病毒藥的靶向給藥是COVID-19研究的重點,呼吸道是COVID-19病毒載量最高的部位。COVID-19解決方案的競爭不僅被認為是利潤和市場佔有率的爭奪,而且還因為死亡人數的增加,成為全球經濟拯救的考量。

本報告審查了全球肺/呼吸道藥物輸送市場,包括到2030年的市場規模和收益預測,份額,趨勢和機會,增長和限制因素,產品/製劑/設備/霧化器,我們提供諸如罐類型,用途,分銷渠道,最終用戶,按地區進行的市場分析,競爭狀況以及主要公司的概況等信息。

目錄

第1章報告概述

第2章簡介

第3章執行摘要

  • 電子劑量計數器MDI,集聚囊泡技術和超臨界流體技術等技術進步促進市場增長
  • 成熟市場中行業公司之間的激烈競爭
  • 對日本,中國和印度等新興經濟體提供的增長機會的期望

第4章行業考慮

  • 成長因素
    • 由於技術進步(例如在治療性藥物遞送方法中使用納米顆粒和聚合物載體)導致的市場增長
    • 通過增加呼吸道疾病的患病率和發病率來促進市場增長
    • 醫療保健部門對呼吸系統疾病的意識以及政府促進增長的舉措
  • 抑制因素
    • 嚴格的政府法規
    • 公司之間的激烈競爭
  • 趨勢
    • 智能/數位吸入器簡介
    • 肺部藥物輸送的最新進展
    • MDI技術的趨勢
    • DPI技術的趨勢
    • 不斷發展的肺部藥物輸送
    • 可以最大程度減少全身副作用的肺部藥物遞送
    • 可吸入治療劑的未來
    • 提供競爭力的替代解決方案
  • 行業分析:波特的五力分析

第5章市場分析:按產品分類(2020-2030)

  • 按產品劃分的市場預測(包括COVID之前和恢復的情況)
  • 配方:穩定的增長率
  • 設備:到2030年的最高增長率

第6章市場分析:按公式(2020-2030)

  • 按公式劃分的市場預測(包括COVID前和恢復情景)
  • 懸浮氣霧劑
  • 解決方案氣霧劑領域
  • 乾粉配方:佔據大部分市場份額

第7章市場分析:按設備(2020-2030)

  • 按設備進行的市場預測(包括COVID前和恢復方案)
  • MDI:緊湊方便的呼吸運動,呼吸調節,速度變化解決由於最近推出的MDI設備而引起的與運動調節有關的問題
  • DPI:化學穩定性高於液體製劑
  • 霧化器:一般用於治療呼吸性囊性纖維化,哮喘,COPD和其他疾病
  • 配件

第8章市場分析:霧化器(2020-2030)

  • 霧化器的市場預測(包括預COVID和恢復方案)
  • 軟霧化霧化器:佔據大部分市場份額
  • 噴射霧化器:到2030年最高增長率
  • 超聲波霧化器:與噴射霧化器相比價格更高,傾向於提高噴射化學藥品的溫度

第9章市場分析:按容器類型

  • 按罐類型進行的市場預測(包括COVID之前的版本和恢復方案)
  • 普通罐:佔據大部分市場份額
  • 塗層罐:從2020年到2030年的增長率超過8%

第10章市場分析:按應用(2020-2030)

  • 按應用劃分的市場預測(包括COVID之前和恢復的情況)
  • 哮喘:佔據大部分市場佔有率
  • COPD:2020年至2030年最高增長率
  • 囊性纖維化:在美國的白人人群中常見的遺傳性疾病,在2500至3500個白人新生兒中,有1個發生。
  • 其他用途

第11章市場分析:按分銷渠道(2020-2030)

  • 按分銷渠道進行的市場預測(包括COVID之前和恢復的情況)
  • 零售藥房
  • 醫院藥房:將在2020年佔據大部分市場佔有率
  • 電子商務:2020年至2030年的最高增長率

第12章市場分析:按最終用戶(2020-2030)

  • 最終用戶的市場預測(包括預COVID和恢復方案)
  • 醫院/診所
  • 家庭醫療

第13章市場分析:按地區和主要國家劃分(2020-2030)

  • 區域市場預測

第14章北美

  • 國家市場預測(2020-2030)
  • 產品市場預測
  • 通過公式預測市場
  • 設備市場預測
  • 霧化器的市場預測
  • 按罐類型劃分的市場預測
  • 按應用預測的市場
  • 分銷渠道的市場預測
  • 最終用戶的市場預測
  • 美國市場預測(2020-2030)
  • 加拿大市場預測(2020-2030)

第15章歐洲

第16章亞太地區

第17章拉丁美洲

第18章中東和非洲

第19章公司分析

  • GlaxoSmithKline plc
  • Respironics, Inc.
  • Boehringer Ingelheim
  • 3M
  • AstraZeneca
  • Merck & Co., Inc.
  • Novartis AG
  • OMRON Corporation
  • Sunovion Pharmaceuticals Inc.
  • Teva Pharmaceutical
  • F. Hoffmann-La Roche Ltd.
  • Cipla
  • Pulmatrix
  • Respiratorius AB
  • Regeneron Pharmaceuticals, Inc.
  • Grifols, S.A.
  • Innoviva

第20章結論

  • 後記
  • 正在考慮替代解決方案的公司
  • 吸入藥物的尋求藥物
  • 創新的粒子工程技術和納米技術
目錄
Product Code: PHA0927

Title:
Pulmonary/Respiratory Drug Delivery Market Report 2020-2030
Forecasts by Product (Formulation, Devices), Formulation (Suspension Aerosol, Solution Aerosol, Dry Powder Formulation), Devices (MDIs, DPIs, Nebulizers, Accessories), Nebulizers (Soft Mist Nebulizers, Jet Nebulizers, Ultrasonic Nebulizers), Canister Type (Plain Canisters, Coated Canister), Application (Asthma, COPD, Cystic Fibrosis, Other Applications), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, E-Commerce), End-user (Hospitals & Clinics, Homecare Settings), by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) PLUS Profiles of Leading Respiratory Drug Delivery Companies PLUS COVID-19 Recovery Scenarios.

The targeted delivery of antivirals to where the viral load from COVID-19 is heaviest, the respiratory tract, is at the centre of some COVID-19 work. The race for a COVID-19 solution is not just a race for profit or market share, but a race to save increased death, and rescue the global economy.

But it is not just COVID-19 that steers the future of Pulmonary and respiratory drug delivery. This unique senior report tells you what direction the market will take - and it tells you today.

Discover how to stay ahead

  • Our 500+ page report provides 500+ tables and charts/graphs.
  • Discover the most lucrative areas in your industry and the future market prospects.
  • Forecasted sales at overall world market, regional level and specific country breakdown.
  • Dedicated financial results, trends, opportunities, and revenue predictions.
  • Great opportunities still remain throughout the Pulmonary/Respiratory Drug Delivery Market. See how to exploit the opportunities.

UNIQUE COVID-19 VARIATIONS - only available in this Visiongain report are dedicated analysis of 4 different rebound scenarios of how the market will develop - no matter how COVID-19 affects the economy.

Which Factors are Fueling Respiratory Drug Delivery Industry Growth?

  • Technological Advancements
  • Increase in Prevalence and Incidence of Respiratory Diseases
  • Respiratory Disease Healthcare Awareness

Which Factors are Restraining Growth?

  • Stringent Government Regulations
  • Intense Competition Among Players

What are Market Trends?

  • Introduction of Smart/Digital Inhalers
  • Recent Advances in Pulmonary Drug Delivery
  • Trends in MDI Technology
  • Trends in DPI Technology
  • Pulmonary Drug Delivery will continue to Evolve
  • Pulmonary Drug Delivery Can Minimize Systemic Side Effects
  • Future of Inhalable Therapeutics
  • Alternative Solution to provide Competitive Edge

How do prominent players strengthen their position throughout the world?

You must read this newly updated report if you are involved in this sector. The report from Visiongain gives you key potential revenues up to 2030, evaluates critical development information, trends, opportunities and business outlooks.

Forecasts to 2030 and other analyses reveal the commercial prospects

  • In addition to revenue forecasting to 2030, our new study provides you with recent results, growth rates, and market shares.
  • You find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), SWOT Analysis, Porter's Analysis, product profiles and commercial developments.

Discover sales predictions for the world market and submarkets

Product

  • Formulation
  • Devices

Formulation

  • Suspension Aerosol
  • Solution Aerosol
  • Dry Powder Formulation

Devices

  • MDIs
  • DPIs
  • Nebulizers
  • Accessories

Nebulizers

  • Soft Mist Nebulizers
  • Jet Nebulizers
  • Ultrasonic Nebulizers

Canister Type

  • Plain Canisters
  • Coated Canister

Application

  • Asthma
  • COPD
  • Cystic Fibrosis
  • Other Applications

Distribution Channel

  • Retail Pharmacies
  • Hospital Pharmacies
  • E-Commerce

End-User

  • Hospitals & Clinics
  • Homecare Settings

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 18 leading national markets:

By Region (Segmental Breakdown for All the Regions)

  • North America:
    • U.S.
    • Canada
  • Europe:
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Belgium
    • Switzerland
    • Rest of Europe
  • Asia Pacific:
    • China
    • Japan
    • India
    • Malaysia
    • Rest of Asia Pacific
  • Latin America:
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Middle East & Africa:
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Leading companies and the potential for market growth

Overall world revenue for Pulmonary/Respiratory Drug Delivery Market will surpass $xx billion in 2020, our work calculates. We predict strong revenue growth through to 2030. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

Prospects for established firms and those seeking to enter the market- including company profiles for 17 of the major companies involved in the Respiratory Drug Delivery Market. Some of the companies profiled in this report include GlaxoSmithKline plc, Respironics, Inc., Boehringer Ingelheim, 3M, AstraZeneca, Merck & Co., Inc., Novartis AG, OMRON Corporation, Sunovion Pharmaceuticals Inc., Teva Pharmaceutical, F. Hoffmann-La Roche Ltd., Cipla, Pulmatrix, Respiratorius AB, Regeneron Pharmaceuticals, Inc., Grifols, S.A., and Innoviva

Key Questions Answered by this Report:

  • What is the current size of the overall global pulmonary/respiratory drug delivery market? How much will this market be worth from 2020 to 2030?
  • What are the main drivers and restraints that will shape the overall respiratory drug delivery market over the next ten years?
  • What are the main segments within the overall pulmonary/respiratory drug delivery market? How much will each of these segments be worth for the period 2020 to 2030? How will the composition of the market change during that time, and why?
  • What factors will affect that industry and market over the next ten years?
  • What are the largest national markets for the world pulmonary/respiratory drug delivery? What is their current status and how will they develop over the next ten years? What are their revenue potentials to 2030?
  • How will market shares of the leading national markets change by 2030, and which geographical region will lead the market in 2030?
  • Which are the leading companies and what are their activities, results, developments, and prospects?
  • What are the main trends that will affect the world pulmonary/respiratory drug delivery market between 2020 and 2030?
  • What are the main strengths, weaknesses, opportunities, and threats for the market?
  • How will the global pulmonary/respiratory drug delivery market evolve over the forecasted period, 2020 to 2030?
  • How will market shares of prominent national markets change from 2020, and which countries will lead the market in 2030, achieving highest revenues and fastest growth?

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else

With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.

Visiongain's study is intended for everybody needing commercial analyses for the Global Pulmonary/Respiratory Drug Delivery Market and leading companies. You will find data, trends and predictions.

Buy our report today Pulmonary/Respiratory Drug Delivery Market Report 2020-2030: Forecasts by Product (Formulation, Devices), Formulation (Suspension Aerosol, Solution Aerosol, Dry Powder Formulation), Devices (MDIs, DPIs, Nebulizers, Accessories), Nebulizers (Soft Mist Nebulizers, Jet Nebulizers, Ultrasonic Nebulizers), Canister Type (Plain Canisters, Coated Canister), Application (Asthma, COPD, Cystic Fibrosis, Other Applications), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, E-Commerce), End-user (Hospitals & Clinics, Homecare Settings), by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) PLUS Profiles of Leading Respiratory Drug Delivery Companies. Avoid missing out by staying informed - order our report now.

Visiongain is a trading partner with the US Federal Government.

Table of Contents

1 Report Overview

  • 1.1 Respiratory Drug Delivery Market Definition
  • 1.2 Why You Should Read This Report
  • 1.3 What This Report Delivers
  • 1.4 Key Questions Answered By This Analytical Report Include:
  • 1.5 Who is This Report For?
  • 1.6 Methodology
    • 1.6.1 COVID-19 Impact: Recovery Scenarios
    • 1.6.2 Market Evaluation & Forecasting Methodology
  • 1.7 Frequently Asked Questions (FAQs)
  • 1.8 Associated Visiongain Reports
  • 1.9 About Visiongain

2 Introduction to Respiratory Drug Delivery

  • 2.1 What is Respiratory Drug Delivery?
  • 2.2 Role and Function of Pulmonary/Respiratory Drug Delivery
  • 2.3 Pros & Cons of Respiratory Drug Delivery
  • 2.4 Prevalence of Respiratory Diseases: Approximately 65 million people have moderate to severe COPD

3 Executive Summary

  • 3.1 Technological Advancements Like Electronic Dose Counter MDI, Incorporation of Agglomerated Vesicle Technology, and Technology for Supercritical Fluids to Fuel Market Growth
  • 3.2 Stiff Competition Among Industry Players Owing to Highly Mature Market
  • 3.3 Emerging Economies like Japan, China, and India Are Expected to Offer Lucrative Growth Opportunities

4 Industry Insights

  • 4.1 Drivers
    • 4.1.1 Technological Advancements Such as Use of Nanoparticles and Polymeric Carriers in The Method of Delivering Therapeutic Drugs to Attract Market Growth
    • 4.1.2 Increase in Prevalence and Incidence of Respiratory Diseases to Boost Market Growth
    • 4.1.3 Respiratory Disease Healthcare Awareness Coupled with Government Initiatives to Fuel Growth
  • 4.2 Restraints
    • 4.2.1 Stringent Government Regulations
    • 4.2.2 Intense Competition Among Players
  • 4.3 Trends
    • 4.3.1 Introduction of Smart/Digital Inhalers
    • 4.3.2 Recent Advances in Pulmonary Drug Delivery
    • 4.3.3 Trends in MDI Technology
    • 4.3.4 Trends in DPI Technology
    • 4.3.5 Pulmonary Drug Delivery will continue to Evolve
    • 4.3.6 Pulmonary Drug Delivery Can Minimize Systemic Side Effects
    • 4.3.7 Future of Inhalable Therapeutics
    • 4.3.8 Alternative Solution to provide Competitive Edge
  • 4.4 Industry analysis - Porter's
    • 4.4.1 Buyer Power: Moderate
    • 4.4.2 Supplier Power: Moderate
    • 4.4.3 Competitive Rivalry: High
    • 4.4.4 Threat of Substitute: Moderate
    • 4.4.5 Threat of New Entrants: Low to Medium

5 Respiratory Drug Delivery Market by Product, 2020-2030

  • 5.1 Market Forecast by Product (Pre COVID & Recovery Scenarios Included)
  • 5.2 Formulation Segment to Witness Lucrative Growth Rate
  • 5.3 Devices Segment to Witness Highest Growth Rate Through 2030

6 Respiratory Drug Delivery Market by Formulation, 2020-2030

  • 6.1 Market Forecast by Formulation (Pre COVID & Recovery Scenarios Included)
  • 6.2 Suspension Aerosol to Surpass US$ ~XX bn by 2025
  • 6.3 Solution Aerosol Segment to Garner a CAGR of ~XX%
  • 6.4 Dry Powder Formulation Accounted for Majority of the Market Share

7 Respiratory Drug Delivery Market by Devices, 2020-2030

  • 7.1 Market Forecast by Devices (Pre COVID & Recovery Scenarios Included)
  • 7.2 MDIs: Recent Introduction of Compact and Convenient Breath-Actuated, Breath-Coordinated and Speed-Modifying MDI Devices Has Successfully Addressed Problems Related to Actuation Coordination
  • 7.3 DPIs: DPI drug formulations have greater chemical stability than liquid formulations
    • 7.3.1 Opportunities in other Therapeutic Areas
    • 7.3.2 Capsule Based DPI Technology Provides Greater Freedom to Innovate
  • 7.4 Nebulizers: Are commonly used in the treatment of respiratory system cystic fibrosis, asthma, COPD and other diseases or disorders
  • 7.5 Accessories

8 Respiratory Drug Delivery Market by Nebulizers, 2020-2030

  • 8.1 Market Forecast by Nebulizers (Pre COVID & Recovery Scenarios Included)
  • 8.2 Soft Mist Nebulizers Accounted for the Majority of the Market Share
  • 8.3 Jet Nebulizers to Witness Highest Growth Rate Through 2030
  • 8.4 Ultrasonic Nebulizers: Are more expensive compared to jet nebulizers and tend to increase the temperature of the nebulized drug solution

9 Respiratory Drug Delivery Market by Canister Type

  • 9.1 Market Forecast by Canister Type (Pre COVID & Recovery Scenarios Included)
  • 9.2 Plain Canisters Accounted for the Majority of the Market Share
  • 9.3 Coated Canister to Witness Highest Growth Rate of over 8% from 2020 to 2030

10 Respiratory Drug Delivery Market by Application, 2020-2030

  • 10.1 Market Forecast by Application (Pre COVID & Recovery Scenarios Included)
  • 10.2 Asthma Accounted for the Majority of the Market Share
  • 10.3 COPD to Witness Highest Growth Rate from 2020 to 2030
  • 10.4 Cystic Fibrosis is a Common Genetic Disease in The United States White Population which Occurs 1 in 2,500 to 3,500 White New-Borns
  • 10.5 Other Applications

11 Respiratory Drug Delivery Market by Distribution Channel, 2020-2030

  • 11.1 Market Forecast by Distribution Channel (Pre COVID & Recovery Scenarios Included)
  • 11.2 Retail Pharmacies
  • 11.3 Hospital Pharmacies Accounted for Majority of the Market Share in 2020
  • 11.4 E-Commerce to Witness Highest Growth Rate from 2020 to 2030

12 Respiratory Drug Delivery Market by End-User, 2020-2030

  • 12.1 Market Forecast by End-User (Pre COVID & Recovery Scenarios Included)
  • 12.2 Hospitals & Clinics
  • 12.3 Homecare Settings

13 Regional and Leading National Respiratory Drug Delivery Market Forecasts 2020-2030

  • 13.1 Global Respiratory Drug Delivery Market by Region Forecast 2020-2030
    • 13.1.1 Recovery Scenarios (V, U, W, L)

14 North America

  • 14.1 North America Respiratory Drug Delivery Market by Country Forecast 2020-2030
  • 14.2 North America Respiratory Drug Delivery Market Forecast by Product
  • 14.3 North America Respiratory Drug Delivery Market Forecast by Formulation
  • 14.4 North America Respiratory Drug Delivery Market Forecast by Devices
  • 14.5 North America Respiratory Drug Delivery Market Forecast by Nebulizers
  • 14.6 North America Respiratory Drug Delivery Market Forecast by Canister Type
  • 14.7 North America Respiratory Drug Delivery Market Forecast by Application
  • 14.8 North America Respiratory Drug Delivery Market Forecast by Distribution Channel
  • 14.9 North America Respiratory Drug Delivery Market Forecast by End-User
  • 14.10 U.S. Respiratory Drug Delivery Market Forecast 2020-2030
    • 14.10.1 Dominated the Global Respiratory Drug Delivery Market
    • 14.10.2 Recovery Scenarios (V, U, W, L)
  • 14.11 Canada Respiratory Drug Delivery Market Forecast 2020-2030
    • 14.11.1 Introduction
    • 14.11.2 Recovery Scenarios (V, U, W, L)

15 Europe

  • 15.1 Europe Respiratory Drug Delivery Market by Country Forecast 2020-2030
  • 15.2 Europe Respiratory Drug Delivery Market Forecast by Product
  • 15.3 Europe Respiratory Drug Delivery Market Forecast by Formulation
  • 15.4 Europe Respiratory Drug Delivery Market Forecast by Devices
  • 15.5 Europe Respiratory Drug Delivery Market Forecast by Nebulizers
  • 15.6 Europe Respiratory Drug Delivery Market Forecast by Canister Type
  • 15.7 Europe Respiratory Drug Delivery Market Forecast by Application
  • 15.8 Europe Respiratory Drug Delivery Market Forecast by Distribution Channel
  • 15.9 Europe Respiratory Drug Delivery Market Forecast by End-User
  • 15.10 Germany Respiratory Drug Delivery Market Forecast 2020-2030
    • 15.10.1 Established Healthcare System
    • 15.10.2 Economic Shrinkage Amid COVID-19
    • 15.10.3 Recovery Scenarios (V, U, W, L)
  • 15.11 France Respiratory Drug Delivery Market Forecast 2020-2030
    • 15.11.1 Renowned Medical Care with Innovation
    • 15.11.2 Economic Uncertainty
    • 15.11.3 Fully Integrated Network of Public & Private Hospitals
    • 15.11.4 Recovery Scenarios (V, U, W, L)
  • 15.12 UK Respiratory Drug Delivery Market Forecast 2020-2030
    • 15.12.1 UK Third Largest Medical Device Market in Europe
    • 15.12.2 550,000 Respiratory Diagnosis Annually in UK
    • 15.12.3 Low Economic Burden of Respiratory Diseases
    • 15.12.4 Recovery Scenarios (V, U, W, L)
  • 15.13 Italy Respiratory Drug Delivery Market Forecast 2020-2030
    • 15.13.1 Large Elderly Population
    • 15.13.2 Italy Economy Vulnerable to Economic Shocks
    • 15.13.3 Recovery Scenarios (V, U, W, L)
  • 15.14 Spain Respiratory Drug Delivery Market Forecast 2020-2030
    • 15.14.1 Key Market within European Region
    • 15.14.2 High COPD Prevalence Across the Spanish Region
    • 15.14.3 Recovery Scenarios (V, U, W, L)
  • 15.15 Belgium Respiratory Drug Delivery Market Forecast 2020-2030
    • 15.15.1 Efficient & Accessible Healthcare System
    • 15.15.2 Recovery Scenarios (V, U, W, L)
  • 15.16 Switzerland Respiratory Drug Delivery Market Forecast 2020-2030
    • 15.16.1 COPD Major Health Problem
    • 15.16.2 Recovery Scenarios (V, U, W, L)
  • 15.17 Rest of Europe Respiratory Drug Delivery Market Forecast 2020-2030
    • 15.17.1 Recovery Scenarios (V, U, W, L)

16 Asia Pacific

  • 16.1 Introduction
  • 16.2 Asia Pacific Respiratory Drug Delivery Market by Country Forecast 2020-2030
  • 16.3 Asia Pacific Respiratory Drug Delivery Market Forecast by Product
  • 16.4 Asia Pacific Respiratory Drug Delivery Market Forecast by Formulation
  • 16.5 Asia Pacific Respiratory Drug Delivery Market Forecast by Devices
  • 16.6 Asia Pacific Respiratory Drug Delivery Market Forecast by Nebulizers
  • 16.7 Asia Pacific Respiratory Drug Delivery Market Forecast by Canister Type
  • 16.8 Asia Pacific Respiratory Drug Delivery Market Forecast by Application
  • 16.9 Asia Pacific Respiratory Drug Delivery Market Forecast by Distribution Channel
  • 16.10 Asia Pacific Respiratory Drug Delivery Market Forecast by End-User
  • 16.11 Japan Respiratory Drug Delivery Market Forecast 2020-2030
    • 16.11.1 Ageing Population
    • 16.11.2 Recovery Scenarios (V, U, W, L)
  • 16.12 China Respiratory Drug Delivery Market Forecast 2020-2030
    • 16.12.1 China is the Second Largest Market
    • 16.12.2 Recovery Scenarios (V, U, W, L)
  • 16.13 India Respiratory Drug Delivery Market Forecast 2020-2030
    • 16.13.1 Anticipated to Witness Highest Growth Rate
    • 16.13.2 COPD Continues to be Neglected Across the Indian Region
    • 16.13.3 Recovery Scenarios (V, U, W, L)
  • 16.14 Australia Respiratory Drug Delivery Market Forecast 2020-2030
    • 16.14.1 Introduction
    • 16.14.2 Recovery Scenarios (V, U, W, L)
  • 16.15 Malaysia Respiratory Drug Delivery Market Forecast 2020-2030
    • 16.15.1 Recovery Scenarios (V, U, W, L)
  • 16.16 Rest of Asia Pacific Respiratory Drug Delivery Market Forecast 2020-2030
    • 16.16.1 Recovery Scenarios (V, U, W, L)

17 Latin America

  • 17.1 Latin America Respiratory Drug Delivery Market by Country Forecast 2020-2030
  • 17.2 Latin America Respiratory Drug Delivery Market Forecast by Product
  • 17.3 Latin America Respiratory Drug Delivery Market Forecast by Formulation
  • 17.4 Latin America Respiratory Drug Delivery Market Forecast by Devices
  • 17.5 Latin America Respiratory Drug Delivery Market Forecast by Nebulizers
  • 17.6 Latin America Respiratory Drug Delivery Market Forecast by Canister Type
  • 17.7 Latin America Respiratory Drug Delivery Market Forecast by Application
  • 17.8 Latin America Respiratory Drug Delivery Market Forecast by Distribution Channel
  • 17.9 Latin America Respiratory Drug Delivery Market Forecast by End-User
  • 17.10 Brazil Respiratory Drug Delivery Market Forecast 2020-2030
    • 17.10.1 Introduction
    • 17.10.2 Recovery Scenarios (V, U, W, L)
  • 17.11 Mexico Respiratory Drug Delivery Market Forecast 2020-2030
    • 17.11.1 Introduction
    • 17.11.2 Recovery Scenarios (V, U, W, L)
  • 17.12 Argentina Respiratory Drug Delivery Market Forecast 2020-2030
    • 17.12.1 Recovery Scenarios (V, U, W, L)
  • 17.13 Rest of Latin America Respiratory Drug Delivery Market Forecast 2020-2030
    • 17.13.1 Recovery Scenarios (V, U, W, L)

18 Middle East and Africa

  • 18.1 Middle East and Africa Respiratory Drug Delivery Market by Country Forecast 2020-2030
  • 18.2 Middle East and Africa Respiratory Drug Delivery Market Forecast by Product
  • 18.3 Middle East and Africa Respiratory Drug Delivery Market Forecast by Formulation
  • 18.4 Middle East and Africa Respiratory Drug Delivery Market Forecast by Devices
  • 18.5 Middle East and Africa Respiratory Drug Delivery Market Forecast by Nebulizers
  • 18.6 Middle East and Africa Respiratory Drug Delivery Market Forecast by Canister Type
  • 18.7 Middle East and Africa Respiratory Drug Delivery Market Forecast by Application
  • 18.8 Middle East and Africa Respiratory Drug Delivery Market Forecast by Distribution Channel
  • 18.9 Middle East and Africa Respiratory Drug Delivery Market Forecast by End-User
  • 18.10 GCC Respiratory Drug Delivery Market Forecast 2020-2030
    • 18.10.1 Recovery Scenarios (V, U, W, L)
  • 18.11 South Africa Respiratory Drug Delivery Market Forecast 2020-2030
    • 18.11.1 Highest Mortality Compared Globally
    • 18.11.2 Recovery Scenarios (V, U, W, L)
  • 18.12 Rest of Middle East and Africa Respiratory Drug Delivery Market Forecast 2020-2030
    • 18.12.1 Recovery Scenarios (V, U, W, L)

19 Company Profiling

  • 19.1 GlaxoSmithKline plc
    • 19.1.1 Company Snapshot
    • 19.1.2 Company Overview
    • 19.1.3 Financial Analysis
      • 19.1.3.1 Net Revenue, 2015-2019
      • 19.1.3.2 EBIDTA, 2015-2019
      • 19.1.3.3 Gross Profit, 2015-2019
    • 19.1.4 Products
    • 19.1.5 Recent Developments
  • 19.2 Respironics, Inc.
    • 19.2.1 Company Snapshot
    • 19.2.2 Company Overview
    • 19.2.3 Financial Analysis
      • 19.2.3.1 Net Revenue, 2015-2019
      • 19.2.3.2 EBIDTA, 2015-2019
      • 19.2.3.3 Gross Profit, 2015-2019
    • 19.2.4 Products
  • 19.3 Boehringer Ingelheim
    • 19.3.1 Company Snapshot
    • 19.3.2 Company Overview
    • 19.3.3 Financial Analysis
      • 19.3.3.1 Net Revenue, 2015-2019
    • 19.3.4 Products
    • 19.3.5 Recent Developments
  • 19.4 3M
    • 19.4.1 Company Snapshot
    • 19.4.2 Company Overview
    • 19.4.3 Financial Analysis
      • 19.4.3.1 Net Revenue, 2015-2019
      • 19.4.3.2 EBIDTA, 2015-2019
      • 19.4.3.3 Gross Profit, 2015-2019
    • 19.4.4 Products
  • 19.5 AstraZeneca
    • 19.5.1 Company Snapshot
    • 19.5.2 Company Overview
    • 19.5.3 Financial Analysis
      • 19.5.3.1 Net Revenue, 2015-2019
      • 19.5.3.2 EBIDTA, 2015-2019
      • 19.5.3.3 Gross Profit, 2015-2019
    • 19.5.4 Products
    • 19.5.5 Recent Developments
  • 19.6 Merck & Co., Inc.
    • 19.6.1 Company Snapshot
    • 19.6.2 Company Overview
    • 19.6.3 Financial Analysis
      • 19.6.3.1 Net Revenue, 2015-2019
      • 19.6.3.2 EBIDTA, 2015-2019
      • 19.6.3.3 Gross Profit, 2015-2019
    • 19.6.4 Products
  • 19.7 Novartis AG
    • 19.7.1 Company Snapshot
    • 19.7.2 Company Overview
    • 19.7.3 Financial Analysis
      • 19.7.3.1 Net Revenue, 2015-2019
      • 19.7.3.2 EBIDTA, 2015-2019
      • 19.7.3.3 Gross Profit, 2015-2019
    • 19.7.4 Products
    • 19.7.5 Recent Developments
  • 19.8 OMRON Corporation
    • 19.8.1 Company Snapshot
    • 19.8.2 Company Overview
    • 19.8.3 Financial Analysis
      • 19.8.3.1 Net Revenue, 2015-2019
      • 19.8.3.2 Gross Profit, 2015-2019
    • 19.8.4 Products
  • 19.9 Sunovion Pharmaceuticals Inc.
    • 19.9.1 Company Snapshot
    • 19.9.2 Company Overview
    • 19.9.3 Products
    • 19.9.4 Recent Developments
  • 19.10 Teva Pharmaceutical
    • 19.10.1 Company Snapshot
    • 19.10.2 Company Overview
    • 19.10.3 Financial Analysis
      • 19.10.3.1 Net Revenue, 2015-2019
      • 19.10.3.2 EBIDTA, 2015-2019
      • 19.10.3.3 Gross Profit, 2015-2019
    • 19.10.4 Products
    • 19.10.5 Recent Developments
  • 19.11 F. Hoffmann-La Roche Ltd.
    • 19.11.1 Company Snapshot
    • 19.11.2 Company Overview
    • 19.11.3 Financial Analysis
      • 19.11.3.1 Net Revenue, 2015-2019
      • 19.11.3.2 EBIDTA, 2015-2019
      • 19.11.3.3 Gross Profit, 2015-2019
    • 19.11.4 Products
  • 19.12 Cipla
    • 19.12.1 Company Snapshot
    • 19.12.2 Company Overview
    • 19.12.3 Financial Analysis
      • 19.12.3.1 Net Revenue, 2017-2019
      • 19.12.3.2 EBIDTA, 2015-2019
      • 19.12.3.3 Gross Profit, 2015-2019
    • 19.12.4 Products
    • 19.12.5 Recent Developments
    • 19.12.6 Launch Plans for Respiratory Products
  • 19.13 Pulmatrix
    • 19.13.1 Company Snapshot
    • 19.13.2 Company Overview
    • 19.13.3 Financial Analysis
      • 19.13.3.1 Net Revenue, 2015-2019
      • 19.13.3.2 EBIDTA, 2015-2019
      • 19.13.3.3 Gross Profit, 2015-2019
    • 19.13.4 Recent Developments
  • 19.14 Respiratorius AB
    • 19.14.1 Company Snapshot
    • 19.14.2 Company Overview
    • 19.14.3 Products
  • 19.15 Regeneron Pharmaceuticals, Inc.
    • 19.15.1 Company Snapshot
    • 19.15.2 Company Overview
    • 19.15.3 Financial Analysis
      • 19.15.3.1 Net Revenue, 2015-2019
      • 19.15.3.2 EBIDTA, 2015-2019
      • 19.15.3.3 Gross Profit, 2015-2019
    • 19.15.4 Products
    • 19.15.5 Recent Developments
  • 19.16 Grifols, S.A.
    • 19.16.1 Company Snapshot
    • 19.16.2 Company Overview
    • 19.16.3 Financial Analysis
      • 19.16.3.1 Net Revenue, 2015-2019
      • 19.16.3.2 EBIDTA, 2015-2019
      • 19.16.3.3 Gross Profit, 2015-2019
    • 19.16.4 Products
    • 19.16.5 Recent Developments
  • 19.17 Innoviva
    • 19.17.1 Company Overview
    • 19.17.2 Financial Analysis
      • 19.17.2.1 Net Revenue, 2015-2019
      • 19.17.2.2 EBIDTA, 2015-2019
      • 19.17.2.3 Gross Profit, 2015-2019
    • 19.17.3 Products

20 Conclusion

  • 20.1 Concluding Remarks
  • 20.2 Companies Considering Alternative Solutions
  • 20.3 Inhalation Route of Delivery is Increasingly Being Explored for Medicines
  • 20.4 Innovative Particle Engineering Techniques and Nanotechnology

List of Tables

  • Table 1 Global Respiratory Drug Delivery Market Snapshot, 2020 & 2030 (US$ billion, CAGR %)
  • Table 2 Global Respiratory Drug Delivery Market by Product Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 3 Global Respiratory Drug Delivery Market Forecast for Formulation, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 4 Global Respiratory Drug Delivery Market Forecast for Formulation, 2020-2030 (US$ Bn, AGR%, CAGR%) ("V" Shaped Recovery)
  • Table 5 Global Respiratory Drug Delivery Market Forecast for Formulation, 2020-2030 (US$ Bn, AGR%, CAGR%) ("U" Shaped Recovery)
  • Table 6 Global Respiratory Drug Delivery Market Forecast for Formulation, 2020-2030 (US$ Bn, AGR%, CAGR%) ("W" Shaped Recovery)
  • Table 7 Global Respiratory Drug Delivery Market Forecast for Formulation, 2020-2030 (US$ Bn, AGR%, CAGR%) ("L" Shaped Recovery)
  • Table 8 Global Respiratory Drug Delivery Market Forecast for Devices, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 9 Global Respiratory Drug Delivery Market Forecast for Devices, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 10 Global Respiratory Drug Delivery Market Forecast for Devices, 2020-2030 (US$ Bn, AGR%, CAGR%) ("U" Shaped Recovery)
  • Table 11 Global Respiratory Drug Delivery Market Forecast for Devices, 2020-2030 (US$ Bn, AGR%, CAGR%) ("W" Shaped Recovery)
  • Table 12 Global Respiratory Drug Delivery Market Forecast for Devices, 2020-2030 (US$ Bn, AGR%, CAGR%) ("L" Shaped Recovery)
  • Table 13 Global Respiratory Drug Delivery Market by Formulation Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 14 Global Respiratory Drug Delivery Market Forecast for Suspension Aerosol, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 15 Global Respiratory Drug Delivery Market Forecast for Suspension Aerosol, 2020-2030 (US$ Bn, AGR%, CAGR%) ("V" Shaped Recovery)
  • Table 16 Global Respiratory Drug Delivery Market Forecast for Suspension Aerosol, 2020-2030 (US$ Bn, AGR%, CAGR%) ("U" Shaped Recovery)
  • Table 17 Global Respiratory Drug Delivery Market Forecast for Suspension Aerosol, 2020-2030 (US$ Bn, AGR%, CAGR%) ("W" Shaped Recovery)
  • Table 18 Global Respiratory Drug Delivery Market Forecast for Suspension Aerosol, 2020-2030 (US$ Bn, AGR%, CAGR%) ("L" Shaped Recovery)
  • Table 19 Global Respiratory Drug Delivery Market Forecast for Solution Aerosol, 2020-2030 (US$ Bn, AGR%, CAGR%) ("V" Shaped Recovery)
  • Table 20 Global Respiratory Drug Delivery Market Forecast for Solution Aerosol, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 21 Global Respiratory Drug Delivery Market Forecast for Solution Aerosol, 2020-2030 (US$ Bn, AGR%, CAGR%) ("U" Shaped Recovery)
  • Table 22 Global Respiratory Drug Delivery Market Forecast for Solution Aerosol, 2020-2030 (US$ Bn, AGR%, CAGR%) ("W" Shaped Recovery)
  • Table 23 Global Respiratory Drug Delivery Market Forecast for Solution Aerosol, 2020-2030 (US$ Bn, AGR%, CAGR%) ("L" Shaped Recovery)
  • Table 24 Global Respiratory Drug Delivery Market Forecast for Dry Powder Formulation, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 25 Global Respiratory Drug Delivery Market Forecast for Dry Powder Aerosol, 2020-2030 (US$ Bn, AGR%, CAGR%) ("V" Shaped Recovery)
  • Table 26 Global Respiratory Drug Delivery Market Forecast for Dry Powder Aerosol, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 27 Global Respiratory Drug Delivery Market Forecast for Dry Powder Aerosol, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 28 Global Respiratory Drug Delivery Market Forecast for Dry Powder Aerosol, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 29 Global Respiratory Drug Delivery Market Forecast for MDIs, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 30 Global Respiratory Drug Delivery Market Forecast for MDIs, 2020-2030 (US$ Bn, AGR%, CAGR%) ("V" Shaped Recovery)
  • Table 31 Global Respiratory Drug Delivery Market Forecast for MDIs, 2020-2030 (US$ Bn, AGR%, CAGR%) ("U" Shaped Recovery)
  • Table 32 Global Respiratory Drug Delivery Market Forecast for MDIs, 2020-2030 (US$ Bn, AGR%, CAGR%) ("W" Shaped Recovery)
  • Table 33 Global Respiratory Drug Delivery Market Forecast for MDIs, 2020-2030 (US$ Bn, AGR%, CAGR%) ("L" Shaped Recovery)
  • Table 34 Global Respiratory Drug Delivery Market Forecast for DPIs, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 35 Global Respiratory Drug Delivery Market Forecast for DPIs, 2020-2030 (US$ Bn, AGR%, CAGR%) ("V" Shaped Recovery)
  • Table 36 Global Respiratory Drug Delivery Market Forecast for DPIs, 2020-2030 (US$ Bn, AGR%, CAGR%) ("U" Shaped Recovery)
  • Table 37 Global Respiratory Drug Delivery Market Forecast for DPIs, 2020-2030 (US$ Bn, AGR%, CAGR%) ("W" Shaped Recovery)
  • Table 38 Global Respiratory Drug Delivery Market Forecast for DPIs, 2020-2030 (US$ Bn, AGR%, CAGR%) ("L" Shaped Recovery)
  • Table 39 Global Respiratory Drug Delivery Market Forecast for Nebulizers, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 40 Global Respiratory Drug Delivery Market Forecast for Nebulizers, 2020-2030 (US$ Bn, AGR%, CAGR%) ("V" Shaped Recovery)
  • Table 41 Global Respiratory Drug Delivery Market Forecast for Nebulizers, 2020-2030 (US$ Bn, AGR%, CAGR%) ("U" Shaped Recovery)
  • Table 42 Global Respiratory Drug Delivery Market Forecast for Nebulizers, 2020-2030 (US$ Bn, AGR%, CAGR%) ("W" Shaped Recovery)
  • Table 43 Global Respiratory Drug Delivery Market Forecast for Nebulizers, 2020-2030 (US$ Bn, AGR%, CAGR%) ("L" Shaped Recovery)
  • Table 44 Global Respiratory Drug Delivery Market Forecast for Accessories, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 45 Global Respiratory Drug Delivery Market Forecast for Accessories, 2020-2030 (US$ Bn, AGR%, CAGR%) ("V" Shaped Recovery)
  • Table 46 Global Respiratory Drug Delivery Market Forecast for Accessories, 2020-2030 (US$ Bn, AGR%, CAGR%) ("U" Shaped Recovery)
  • Table 47 Global Respiratory Drug Delivery Market Forecast for Accessories, 2020-2030 (US$ Bn, AGR%, CAGR%) ("W" Shaped Recovery)
  • Table 48 Global Respiratory Drug Delivery Market Forecast for Accessories, 2020-2030 (US$ Bn, AGR%, CAGR%) ("L" Shaped Recovery)
  • Table 49 Global Respiratory Drug Delivery Market Forecast for Soft Mist Nebulizers, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 50 Global Respiratory Drug Delivery Market Forecast for Soft Mist Nebulizers, 2020-2030 (US$ Bn, AGR%, CAGR%) ("V" Shaped Recovery)
  • Table 51 Global Respiratory Drug Delivery Market Forecast for Soft Mist Nebulizers, 2020-2030 (US$ Bn, AGR%, CAGR%) ("U" Shaped Recovery)
  • Table 52 Global Respiratory Drug Delivery Market Forecast for Soft Mist Nebulizers, 2020-2030 (US$ Bn, AGR%, CAGR%) ("W" Shaped Recovery)
  • Table 53 Global Respiratory Drug Delivery Market Forecast for Soft Mist Nebulizers, 2020-2030 (US$ Bn, AGR%, CAGR%) ("L" Shaped Recovery)
  • Table 54 Global Respiratory Drug Delivery Market Forecast for Jet Nebulizers, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 55 Global Respiratory Drug Delivery Market Forecast for Jet Nebulizers, 2020-2030 (US$ Bn, AGR%, CAGR%) ("V" Shaped Recovery)
  • Table 56 Global Respiratory Drug Delivery Market Forecast for Jet Nebulizers, 2020-2030 (US$ Bn, AGR%, CAGR%) ("U" Shaped Recovery)
  • Table 57 Global Respiratory Drug Delivery Market Forecast for Jet Nebulizers, 2020-2030 (US$ Bn, AGR%, CAGR%) ("W" Shaped Recovery)
  • Table 58 Global Respiratory Drug Delivery Market Forecast for Jet Nebulizers, 2020-2030 (US$ Bn, AGR%, CAGR%) ("L" Shaped Recovery)
  • Table 59 Global Respiratory Drug Delivery Market Forecast for Ultrasonic Nebulizers, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 60 Global Respiratory Drug Delivery Market Forecast for Ultrasonic Nebulizers, 2020-2030 (US$ Bn, AGR%, CAGR%) ("V" Shaped Recovery)
  • Table 61 Global Respiratory Drug Delivery Market Forecast for Ultrasonic Nebulizers, 2020-2030 (US$ Bn, AGR%, CAGR%) ("U" Shaped Recovery)
  • Table 62 Global Respiratory Drug Delivery Market Forecast for Ultrasonic Nebulizers, 2020-2030 (US$ Bn, AGR%, CAGR%) ("W" Shaped Recovery)
  • Table 63 Global Respiratory Drug Delivery Market Forecast for Ultrasonic Nebulizers, 2020-2030 (US$ Bn, AGR%, CAGR%) ("L" Shaped Recovery)
  • Table 64 Global Respiratory Drug Delivery Market Forecast for Plain Canisters, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 65 Global Respiratory Drug Delivery Market Forecast for Plain Canisters, 2020-2030 (US$ Bn, AGR%, CAGR%) ("V" Shaped Recovery)
  • Table 66 Global Respiratory Drug Delivery Market Forecast for Plain Canisters, 2020-2030 (US$ Bn, AGR%, CAGR%) ("U" Shaped Recovery)
  • Table 67 Global Respiratory Drug Delivery Market Forecast for Plain Canisters, 2020-2030 (US$ Bn, AGR%, CAGR%) ("W" Shaped Recovery)
  • Table 68 Global Respiratory Drug Delivery Market Forecast for Plain Canisters, 2020-2030 (US$ Bn, AGR%, CAGR%) ("L" Shaped Recovery)
  • Table 69 Global Respiratory Drug Delivery Market Forecast for Coated Canisters, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 70 Global Respiratory Drug Delivery Market Forecast for Coated Canisters, 2020-2030 (US$ Bn, AGR%, CAGR%) ("V" Shaped Recovery)
  • Table 71 Global Respiratory Drug Delivery Market Forecast for Coated Canisters, 2020-2030 (US$ Bn, AGR%, CAGR%) ("U" Shaped Recovery)
  • Table 72 Global Respiratory Drug Delivery Market Forecast for Coated Canisters, 2020-2030 (US$ Bn, AGR%, CAGR%) ("W" Shaped Recovery)
  • Table 73 Global Respiratory Drug Delivery Market Forecast for Coated Canisters, 2020-2030 (US$ Bn, AGR%, CAGR%) ("L" Shaped Recovery)
  • Table 74 Global Respiratory Drug Delivery Market Forecast for Asthma, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 75 Global Respiratory Drug Delivery Market Forecast for Asthma, 2020-2030 (US$ Bn, AGR%, CAGR%) ("V" Shaped Recovery)
  • Table 76 Global Respiratory Drug Delivery Market Forecast for Asthma, 2020-2030 (US$ Bn, AGR%, CAGR%) ("U" Shaped Recovery)
  • Table 77 Global Respiratory Drug Delivery Market Forecast for Asthma, 2020-2030 (US$ Bn, AGR%, CAGR%) ("W" Shaped Recovery)
  • Table 78 Global Respiratory Drug Delivery Market Forecast for Asthma, 2020-2030 (US$ Bn, AGR%, CAGR%) ("L" Shaped Recovery)
  • Table 79 Global Respiratory Drug Delivery Market Forecast for COPD, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 80 Global Respiratory Drug Delivery Market Forecast for COPD, 2020-2030 (US$ Bn, AGR%, CAGR%) ("V" Shaped Recovery)
  • Table 81 Global Respiratory Drug Delivery Market Forecast for COPD, 2020-2030 (US$ Bn, AGR%, CAGR%) ("U" Shaped Recovery)
  • Table 82 Global Respiratory Drug Delivery Market Forecast for COPD, 2020-2030 (US$ Bn, AGR%, CAGR%) ("W" Shaped Recovery)
  • Table 83 Global Respiratory Drug Delivery Market Forecast for COPD, 2020-2030 (US$ Bn, AGR%, CAGR%) ("L" Shaped Recovery)
  • Table 84 Global Respiratory Drug Delivery Market Forecast for Cystic Fibrosis, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 85 Global Respiratory Drug Delivery Market Forecast for Cystic Fibrosis, 2020-2030 (US$ Bn, AGR%, CAGR%) ("V" Shaped Recovery)
  • Table 86 Global Respiratory Drug Delivery Market Forecast for Cystic Fibrosis, 2020-2030 (US$ Bn, AGR%, CAGR%) ("U" Shaped Recovery)
  • Table 87 Global Respiratory Drug Delivery Market Forecast for Cystic Fibrosis, 2020-2030 (US$ Bn, AGR%, CAGR%) ("W" Shaped Recovery)
  • Table 88 Global Respiratory Drug Delivery Market Forecast for Cystic Fibrosis, 2020-2030 (US$ Bn, AGR%, CAGR%) ("L" Shaped Recovery)
  • Table 89 Global Respiratory Drug Delivery Market Forecast for Other Applications, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 90 Global Respiratory Drug Delivery Market Forecast for Other Applications, 2020-2030 (US$ Bn, AGR%, CAGR%) ("V" Shaped Recovery)
  • Table 91 Global Respiratory Drug Delivery Market Forecast for Other Applications, 2020-2030 (US$ Bn, AGR%, CAGR%) ("U" Shaped Recovery)
  • Table 92 Global Respiratory Drug Delivery Market Forecast for Other Applications, 2020-2030 (US$ Bn, AGR%, CAGR%) ("W" Shaped Recovery)
  • Table 93 Global Respiratory Drug Delivery Market Forecast for Other Applications, 2020-2030 (US$ Bn, AGR%, CAGR%) ("L" Shaped Recovery)
  • Table 94 Global Respiratory Drug Delivery Market Forecast for Retail Pharmacies, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 95 Global Respiratory Drug Delivery Market Forecast for Retail Pharmacies, 2020-2030 (US$ Bn, AGR%, CAGR%) ("V" Shaped Recovery)
  • Table 96 Global Respiratory Drug Delivery Market Forecast for Retail Pharmacies, 2020-2030 (US$ Bn, AGR%, CAGR%) ("U" Shaped Recovery)
  • Table 97 Global Respiratory Drug Delivery Market Forecast for Retail Pharmacies, 2020-2030 (US$ Bn, AGR%, CAGR%) ("W" Shaped Recovery)
  • Table 98 Global Respiratory Drug Delivery Market Forecast for Retail Pharmacies, 2020-2030 (US$ Bn, AGR%, CAGR%) ("L" Shaped Recovery)
  • Table 99 Global Respiratory Drug Delivery Market Forecast for Hospital Pharmaceis, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 100 Global Respiratory Drug Delivery Market Forecast for Hospital Pharmacies, 2020-2030 (US$ Bn, AGR%, CAGR%) ("V" Shaped Recovery)
  • Table 101 Global Respiratory Drug Delivery Market Forecast for Hospital Pharmacies, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 102 Global Respiratory Drug Delivery Market Forecast for Hospital Pharmacies, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 103 Global Respiratory Drug Delivery Market Forecast for Hospital Pharmacies, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 104 Global Respiratory Drug Delivery Market Forecast for E-Commerce, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 105 Global Respiratory Drug Delivery Market Forecast for E-Commerce, 2020-2030 (US$ Bn, AGR%, CAGR%) ("V" Shaped Recovery)
  • Table 106 Global Respiratory Drug Delivery Market Forecast for E-Commerce, 2020-2030 (US$ Bn, AGR%, CAGR%) ("U" Shaped Recovery)
  • Table 107 Global Respiratory Drug Delivery Market Forecast for E-Commerce, 2020-2030 (US$ Bn, AGR%, CAGR%) ("W" Shaped Recovery)
  • Table 108 Global Respiratory Drug Delivery Market Forecast for E-Commerce, 2020-2030 (US$ Bn, AGR%, CAGR%) ("L" Shaped Recovery)
  • Table 109 Global Respiratory Drug Delivery Market Forecast for Hospitals & Clinics, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 110 Global Respiratory Drug Delivery Market Forecast for Hospitals & Clinics, 2020-2030 (US$ Bn, AGR%, CAGR%) ("V" Shaped Recovery)
  • Table 111 Global Respiratory Drug Delivery Market Forecast for Hospitals & Clinics, 2020-2030 (US$ Bn, AGR%, CAGR%) ("U" Shaped Recovery)
  • Table 112 Global Respiratory Drug Delivery Market Forecast for Hospitals & Clinics, 2020-2030 (US$ Bn, AGR%, CAGR%) ("W" Shaped Recovery)
  • Table 113 Global Respiratory Drug Delivery Market Forecast for Hospitals & Clinics, 2020-2030 (US$ Bn, AGR%, CAGR%) ("L" Shaped Recovery)
  • Table 114 Global Respiratory Drug Delivery Market Forecast for Homecare Settings, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 115 Global Respiratory Drug Delivery Market Forecast for Homecare Settings, 2020-2030 (US$ Bn, AGR%, CAGR%) ("V" Shaped Recovery)
  • Table 116 Global Respiratory Drug Delivery Market Forecast for Homecare Settings, 2020-2030 (US$ Bn, AGR%, CAGR%) ("U" Shaped Recovery)
  • Table 117 Global Respiratory Drug Delivery Market Forecast for Homecare Settings, 2020-2030 (US$ Bn, AGR%, CAGR%) ("W" Shaped Recovery)
  • Table 118 Global Respiratory Drug Delivery Market Forecast for Homecare Settings, 2020-2030 (US$ Bn, AGR%, CAGR%) ("L" Shaped Recovery)
  • Table 119 Global Respiratory Drug Delivery Market by Region Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 120 Global Respiratory Drug Delivery Market by Region Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("U" Shaped Recovery)
  • Table 121 Global Respiratory Drug Delivery Market by Region Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("L" Shaped Recovery)
  • Table 122 North America Respiratory Drug Delivery Market by Country Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 123 North America Respiratory Drug Delivery Market by Product Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 124 North America Respiratory Drug Delivery Market by Formulation Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 125 North America Respiratory Drug Delivery Market by Devices Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 126 North America Respiratory Drug Delivery Market by Nebulizers Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 127 North America Respiratory Drug Delivery Market by Canister Type Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 128 North America Respiratory Drug Delivery Market by Application Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 129 North America Respiratory Drug Delivery Market by Distribution Channel Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 130 North America Respiratory Drug Delivery Market by End-User Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 131 U.S. Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 132 U.S. Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("V" Shaped Recovery) ("V" Shaped Recovery)
  • Table 133 U.S. Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("U" Shaped Recovery)
  • Table 134 U.S. Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("W" Shaped Recovery)
  • Table 135 U.S. Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("L" Shaped Recovery)
  • Table 136 Canada Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 137 Canada Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("V" Shaped Recovery) ("V" Shaped Recovery)
  • Table 138 Canada Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("U" Shaped Recovery)
  • Table 139 Canada Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("W" Shaped Recovery)
  • Table 140 Canada Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("L" Shaped Recovery)
  • Table 141 Europe Respiratory Drug Delivery Market by Country Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 142 Europe Respiratory Drug Delivery Market by Product Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 143 Europe Respiratory Drug Delivery Market by Formulation Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 144 Europe Respiratory Drug Delivery Market by Devices Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 145 Europe Respiratory Drug Delivery Market by Nebulizers Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 146 Europe Respiratory Drug Delivery Market by Canister Type Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 147 Europe Respiratory Drug Delivery Market by Application Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 148 Europe Respiratory Drug Delivery Market by Distribution Channel Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 149 Europe Respiratory Drug Delivery Market by End-User Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 150 Germany Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 151 Germany Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("V" Shaped Recovery) ("V" Shaped Recovery)
  • Table 152 Germany Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("U" Shaped Recovery)
  • Table 153 Germany Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("W" Shaped Recovery)
  • Table 154 Germany Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("L" Shaped Recovery)
  • Table 155 France Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 156 France Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("V" Shaped Recovery)
  • Table 157 France Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("U" Shaped Recovery)
  • Table 158 France Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("W" Shaped Recovery)
  • Table 159 France Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("L" Shaped Recovery)
  • Table 160 UK Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 161 UK Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("V" Shaped Recovery)
  • Table 162 UK Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("U" Shaped Recovery)
  • Table 163 UK Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("W" Shaped Recovery)
  • Table 164 UK Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("L" Shaped Recovery)
  • Table 165 Italy Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 166 Italy Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("V" Shaped Recovery)
  • Table 167 Italy Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("U" Shaped Recovery)
  • Table 168 Italy Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("W" Shaped Recovery)
  • Table 169 Italy Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("L" Shaped Recovery)
  • Table 170 Spain Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 171 Spain Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("V" Shaped Recovery)
  • Table 172 Spain Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("U" Shaped Recovery)
  • Table 173 Spain Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("W" Shaped Recovery)
  • Table 174 Spain Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("L" Shaped Recovery)
  • Table 175 EU7 Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 176 EU7 Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("V" Shaped Recovery)
  • Table 177 Belgium Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("U" Shaped Recovery)
  • Table 178 Belgium Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("W" Shaped Recovery)
  • Table 179 Belgium Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("L" Shaped Recovery)
  • Table 180 EU8 Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 181 EU8 Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("V" Shaped Recovery)
  • Table 182 Switzerland Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("U" Shaped Recovery)
  • Table 183 Switzerland Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("W" Shaped Recovery)
  • Table 184 Switzerland Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("L" Shaped Recovery)
  • Table 185 Rest of Europe Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 186 Rest of Europe Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("V" Shaped Recovery)
  • Table 187 Rest of Europe Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("U" Shaped Recovery)
  • Table 188 Rest of Europe Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("W" Shaped Recovery)
  • Table 189 Rest of Europe Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("L" Shaped Recovery)
  • Table 190 Asia Pacific Respiratory Drug Delivery Market by Region Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 191 Asia Pacific Respiratory Drug Delivery Market by Product Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 192 Asia Pacific Respiratory Drug Delivery Market by Formulation Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 193 Asia Pacific Respiratory Drug Delivery Market by Devices Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 194 Asia Pacific Respiratory Drug Delivery Market by Nebulizers Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 195 Asia Pacific Respiratory Drug Delivery Market by Canister Type Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 196 Asia Pacific Respiratory Drug Delivery Market by Application Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 197 Asia Pacific Respiratory Drug Delivery Market by Distribution Channel Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 198 Asia Pacific Respiratory Drug Delivery Market by End-User Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 199 Japan Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 200 Japan Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("V" Shaped Recovery)
  • Table 201 Japan Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("U" Shaped Recovery)
  • Table 202 Japan Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("W" Shaped Recovery)
  • Table 203 Japan Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("L" Shaped Recovery)
  • Table 204 China Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 205 China Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("V" Shaped Recovery)
  • Table 206 China Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("U" Shaped Recovery)
  • Table 207 China Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("W" Shaped Recovery)
  • Table 208 China Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("L" Shaped Recovery)
  • Table 209 India Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 210 India Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("V" Shaped Recovery)
  • Table 211 India Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("U" Shaped Recovery)
  • Table 212 India Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("W" Shaped Recovery)
  • Table 213 India Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("L" Shaped Recovery)
  • Table 214 Australia Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 215 Australia Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("V" Shaped Recovery)
  • Table 216 Australia Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("U" Shaped Recovery)
  • Table 217 Australia Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("W" Shaped Recovery)
  • Table 218 Australia Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("L" Shaped Recovery)
  • Table 219 Malaysia Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 220 Malaysia Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("V" Shaped Recovery)
  • Table 221 Malaysia Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("U" Shaped Recovery)
  • Table 222 Malaysia Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("W" Shaped Recovery)
  • Table 223 Malaysia Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("L" Shaped Recovery)
  • Table 224 Rest of Asia Pacific Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 225 Rest of Asia Pacific Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("V" Shaped Recovery)
  • Table 226 Rest of Asia Pacific Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("U" Shaped Recovery)
  • Table 227 Rest of Asia Pacific Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("W" Shaped Recovery)
  • Table 228 Rest of Asia Pacific Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("L" Shaped Recovery)
  • Table 229 Latin America Respiratory Drug Delivery Market by Country Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 230 Latin America Respiratory Drug Delivery Market by Product Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 231 Latin America Respiratory Drug Delivery Market by Formulation Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 232 Latin America Respiratory Drug Delivery Market by Devices Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 233 Latin America Respiratory Drug Delivery Market by Nebulizers Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 234 Latin America Respiratory Drug Delivery Market by Canister Type Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 235 Latin America Respiratory Drug Delivery Market by Application Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 236 Latin America Respiratory Drug Delivery Market by Distribution Channel Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 237 Latin America Respiratory Drug Delivery Market by End-User Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 238 Brazil Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 239 Brazil Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("V" Shaped Recovery)
  • Table 240 Brazil Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("U" Shaped Recovery)
  • Table 241 Brazil Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("W" Shaped Recovery)
  • Table 242 Brazil Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("L" Shaped Recovery)
  • Table 243 Mexico Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 244 Mexico Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("V" Shaped Recovery)
  • Table 245 Mexico Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("U" Shaped Recovery)
  • Table 246 Mexico Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("W" Shaped Recovery)
  • Table 247 Mexico Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("L" Shaped Recovery)
  • Table 248 Argentina Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 249 Argentina Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("V" Shaped Recovery)
  • Table 250 Argentina Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("U" Shaped Recovery)
  • Table 251 Argentina Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("W" Shaped Recovery)
  • Table 252 Argentina Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("L" Shaped Recovery)
  • Table 253 Rest of Latin America Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 254 Rest of Latin America Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("V" Shaped Recovery)
  • Table 255 Rest of Latin America Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("U" Shaped Recovery)
  • Table 256 Rest of Latin America Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("W" Shaped Recovery)
  • Table 257 Rest of Latin America Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("L" Shaped Recovery)
  • Table 258 MEA Respiratory Drug Delivery Market by Country Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 259 MEA Respiratory Drug Delivery Market by Product Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 260 MEA Respiratory Drug Delivery Market by Formulation Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 261 MEA Respiratory Drug Delivery Market by Devices Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 262 MEA Respiratory Drug Delivery Market by Nebulizers Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 263 MEA Respiratory Drug Delivery Market by Canister Type Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 264 MEA Respiratory Drug Delivery Market by Application Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 265 MEA Respiratory Drug Delivery Market by Distribution Channel Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 266 MEA Respiratory Drug Delivery Market by End-User Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 267 GCC Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 268 GCC Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("V" Shaped Recovery)
  • Table 269 GCC Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("U" Shaped Recovery)
  • Table 270 GCC Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("W" Shaped Recovery)
  • Table 271 GCC Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("L" Shaped Recovery)
  • Table 272 South Africa Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 273 South Africa Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("V" Shaped Recovery)
  • Table 274 South Africa Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("U" Shaped Recovery)
  • Table 275 South Africa Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("W" Shaped Recovery)
  • Table 276 South Africa Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("L" Shaped Recovery)
  • Table 277 Rest of Middle East and Africa Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%)
  • Table 278 Rest of Middle East and Africa Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("V" Shaped Recovery) ("V" Shaped Recovery)
  • Table 279 Rest of Middle East and Africa Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("U" Shaped Recovery)
  • Table 280 Rest of Middle East and Africa Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("W" Shaped Recovery)
  • Table 281 Rest of Middle East and Africa Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ Bn, AGR%, CAGR%) ("L" Shaped Recovery)
  • Table 282 GlaxoSmithKline plc: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 283 GlaxoSmithKline plc: Product Portfolio
  • Table 284 Respironics, Inc.: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 285 Respironics, Inc.: Product Portfolio
  • Table 286 Boehringer Ingelheim: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 287 Boehringer Ingelheim: Product Portfolio
  • Table 288 3M: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 289 3M: Product Portfolio
  • Table 290 AstraZeneca: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 291 AstraZeneca: Product Portfolio
  • Table 292 Merck & Co., Inc.: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 293 Merck & Co., Inc.: Product Portfolio
  • Table 294 Novartis AG: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 295 Novartis AG: Product Portfolio
  • Table 296 OMRON Corporation: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 297 OMRON Corporation: Product Portfolio
  • Table 298 Sunovion Pharmaceuticals Inc.: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 299 Sunovion Pharmaceuticals Inc.: Product Portfolio
  • Table 300 Teva Pharmaceutical: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 301 Teva Pharmaceuticals: Product Portfolio
  • Table 302 F. Hoffmann-La Roche Ltd.: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 303 F. Hoffmann-La Roche Ltd.: Product Portfolio
  • Table 304 Cipla: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 305 Cipla: Product Portfolio
  • Table 306 Pulmatrix: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 307 Respiratorius AB: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 308 Respiratorius AB: Product Portfolio
  • Table 309 Regeneron Pharmaceuticals, Inc.: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 310 Regeneron Pharmaceuticals (Sanofi): Product Pipeline Portfolio
  • Table 311 Grifols, S.A.: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 312 Grifols, S.A.: Product Portfolio
  • Table 313 Innoviva: Product Portfolio

List of Figures

  • Figure 1 Global Respiratory Drug Delivery Market Forecast by Product, 2020-2030 (US$ billion)
  • Figure 2 Global Respiratory Drug Delivery Market Forecast by Formulation, 2020-2030 (US$ billion)
  • Figure 3 Global Respiratory Drug Delivery Market Forecast by Devices, 2020-2030 (US$ billion)
  • Figure 4 Global Respiratory Drug Delivery Market Forecast by Nebulizers, 2020-2030 (US$ billion)
  • Figure 5 Global Respiratory Drug Delivery Market Forecast by Canister Type, 2020-2030 (US$ billion)
  • Figure 6 Global Respiratory Drug Delivery Market Forecast by Application, 2020-2030 (US$ billion)
  • Figure 7 Global Respiratory Drug Delivery Market Forecast by ProductG 2020-2030 (US$ billion)
  • Figure 8 Global Respiratory Drug Delivery Market: Market Trends
  • Figure 9 Global Respiratory Drug Delivery Market: SWOT Analysis
  • Figure 10 Porter's Analysis
  • Figure 11 PEST Analysis
  • Figure 12 Global Respiratory Drug Delivery Market Forecast by Product, 2020-2030 (US$ billion, AGR %)
  • Figure 13 Global Respiratory Drug Delivery Market Share Forecast by Product, 2020, 2025, 2030 (%)
  • Figure 14 Global Respiratory Drug Delivery Market for Formulation Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 15 Global Respiratory Drug Delivery Market for Formulation Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 16 Global Respiratory Drug Delivery Market for Formulation Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 17 Global Respiratory Drug Delivery Market for Formulation Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 18 Global Respiratory Drug Delivery Market for Formulation Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 19 Global Respiratory Drug Delivery Market for Devices Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 20 Global Respiratory Drug Delivery Market for Devices Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 21 Global Respiratory Drug Delivery Market for Devices Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 22 Global Respiratory Drug Delivery Market for Devices Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 23 Global Respiratory Drug Delivery Market for Devices Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 24 Global Respiratory Drug Delivery Market Forecast by Formulation, 2020-2030 (US$ billion, AGR %)
  • Figure 25 Global Respiratory Drug Delivery Market Share Forecast by Formulation, 2020, 2025, 2030 (%)
  • Figure 26 Global Respiratory Drug Delivery Market for Suspension Aerosol Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 27 Global Respiratory Drug Delivery Market for Suspension Aerosol Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 28 Global Respiratory Drug Delivery Market for Suspension Aerosol Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 29 Global Respiratory Drug Delivery Market for Suspension Aerosol Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 30 Global Respiratory Drug Delivery Market for Suspension Aerosol Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 31 Global Respiratory Drug Delivery Market for Solution Aerosol Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 32 Global Respiratory Drug Delivery Market for Solution Aerosol Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 33 Global Respiratory Drug Delivery Market for Solution Aerosol Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 34 Global Respiratory Drug Delivery Market for Solution Aerosol Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 35 Global Respiratory Drug Delivery Market for Solution Aerosol Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 36 Global Respiratory Drug Delivery Market for Dry Powder Formulation Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 37 Global Respiratory Drug Delivery Market for Dry Powder Formulation Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 38 Global Respiratory Drug Delivery Market for Dry Powder Formulation Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 39 Global Respiratory Drug Delivery Market for Dry Powder Formulation Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 40 Global Respiratory Drug Delivery Market for Dry Powder Formulation Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 41 Global Respiratory Drug Delivery Market Forecast by Devices, 2020-2030 (US$ billion, AGR %)
  • Figure 42 Global Respiratory Drug Delivery Market Share Forecast by Devices, 2020, 2025, 2030 (%)
  • Figure 43 Global Respiratory Drug Delivery Market for MDIs Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 44 Global Respiratory Drug Delivery Market for MDIs Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 45 Global Respiratory Drug Delivery Market for MDIs Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 46 Global Respiratory Drug Delivery Market for MDIs Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 47 Global Respiratory Drug Delivery Market for MDIs Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 48 Global Respiratory Drug Delivery Market for DPIs Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 49 Global Respiratory Drug Delivery Market for DPIs Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 50 Global Respiratory Drug Delivery Market for DPIs Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 51 Global Respiratory Drug Delivery Market for DPIs Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 52 Global Respiratory Drug Delivery Market for DPIs Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 53 Global Respiratory Drug Delivery Market for Nebulizers Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 54 Global Respiratory Drug Delivery Market for Nebulizers Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 55 Global Respiratory Drug Delivery Market for Nebulizers Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 56 Global Respiratory Drug Delivery Market for Nebulizers Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 57 Global Respiratory Drug Delivery Market for Nebulizers Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 58 Global Respiratory Drug Delivery Market for Accessories Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 59 Global Respiratory Drug Delivery Market for Accessories Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 60 Global Respiratory Drug Delivery Market for Accessories Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 61 Global Respiratory Drug Delivery Market for Accessories Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 62 Global Respiratory Drug Delivery Market for Accessories Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 63 Global Respiratory Drug Delivery Market Forecast by Nebulizers, 2020-2030 (US$ billion, AGR %)
  • Figure 64 Global Respiratory Drug Delivery Market Share Forecast by Nebulizers, 2020, 2025, 2030 (%)
  • Figure 65 Global Respiratory Drug Delivery Market for Soft Mist Nebulizers Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 66 Global Respiratory Drug Delivery Market for Soft Mist Nebulizers Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 67 Global Respiratory Drug Delivery Market for Soft Mist Nebulizers Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 68 Global Respiratory Drug Delivery Market for Soft Mist Nebulizers Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 69 Global Respiratory Drug Delivery Market for Soft Mist Nebulizers Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 70 Global Respiratory Drug Delivery Market for Jet Nebulizers Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 71 Global Respiratory Drug Delivery Market for Jet Nebulizers Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 72 Global Respiratory Drug Delivery Market for Jet Nebulizers Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 73 Global Respiratory Drug Delivery Market for Jet Nebulizers Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 74 Global Respiratory Drug Delivery Market for Jet Nebulizers Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 75 Global Respiratory Drug Delivery Market for Ultrasonic Nebulizers Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 76 Global Respiratory Drug Delivery Market for Ultrasonic Nebulizers Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 77 Global Respiratory Drug Delivery Market for Ultrasonic Nebulizers Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 78 Global Respiratory Drug Delivery Market for Ultrasonic Nebulizers Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 79 Global Respiratory Drug Delivery Market for Ultrasonic Nebulizers Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 80 Global Respiratory Drug Delivery Market Forecast by Canister Type, 2020-2030 (US$ billion, AGR %)
  • Figure 81 Global Respiratory Drug Delivery Market Share Forecast by Canister Type, 2020, 2025, 2030 (%)
  • Figure 82 Global Respiratory Drug Delivery Market for Plain Canisters Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 83 Global Respiratory Drug Delivery Market for Plain Canisters Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 84 Global Respiratory Drug Delivery Market for Plain Canisters Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 85 Global Respiratory Drug Delivery Market for Plain Canisters Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 86 Global Respiratory Drug Delivery Market for Plain Canisters Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 87 Global Respiratory Drug Delivery Market for Coated Canister Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 88 Global Respiratory Drug Delivery Market for Coated Canister Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 89 Global Respiratory Drug Delivery Market for Coated Canister Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 90 Global Respiratory Drug Delivery Market for Coated Canister Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 91 Global Respiratory Drug Delivery Market for Coated Canister Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 92 Global Respiratory Drug Delivery Market Forecast by Application, 2020-2030 (US$ billion, AGR %)
  • Figure 93 Global Respiratory Drug Delivery Market Share Forecast by Application, 2020, 2025, 2030 (%)
  • Figure 94 Global Respiratory Drug Delivery Market for Asthma Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 95 Global Respiratory Drug Delivery Market for Asthma Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 96 Global Respiratory Drug Delivery Market for Asthma Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 97 Global Respiratory Drug Delivery Market for Asthma Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 98 Global Respiratory Drug Delivery Market for Asthma Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 99 Global Respiratory Drug Delivery Market for COPD Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 100 Global Respiratory Drug Delivery Market for COPD Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 101 Global Respiratory Drug Delivery Market for COPD Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 102 Global Respiratory Drug Delivery Market for COPD Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 103 Global Respiratory Drug Delivery Market for COPD Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 104 Global Respiratory Drug Delivery Market for Cystic Fibrosis Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 105 Global Respiratory Drug Delivery Market for Cystic Fibrosis Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 106 Global Respiratory Drug Delivery Market for Cystic Fibrosis Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 107 Global Respiratory Drug Delivery Market for Cystic Fibrosis Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 108 Global Respiratory Drug Delivery Market for Cystic Fibrosis Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 109 Global Respiratory Drug Delivery Market for Other Applications Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 110 Global Respiratory Drug Delivery Market for Other Applications Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 111 Global Respiratory Drug Delivery Market for Other Applications Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 112 Global Respiratory Drug Delivery Market for Other Applications Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 113 Global Respiratory Drug Delivery Market for Other Applications Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 114 Global Respiratory Drug Delivery Market Forecast by Distribution Channel, 2020-2030 (US$ billion, AGR %)
  • Figure 115 Global Respiratory Drug Delivery Market Share Forecast by Distribution Channel, 2020, 2025, 2030 (%)
  • Figure 116 Global Respiratory Drug Delivery Market for Retail Pharmacies Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 117 Global Respiratory Drug Delivery Market for Retail Pharmacies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 118 Global Respiratory Drug Delivery Market for Retail Pharmacies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 119 Global Respiratory Drug Delivery Market for Retail Pharmacies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 120 Global Respiratory Drug Delivery Market for Retail Pharmacies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 121 Global Respiratory Drug Delivery Market for Hospital Pharmacies Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 122 Global Respiratory Drug Delivery Market for Hospital Pharmacies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 123 Global Respiratory Drug Delivery Market for Hospital Pharmacies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 124 Global Respiratory Drug Delivery Market for Hospital Pharmacies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 125 Global Respiratory Drug Delivery Market for Hospital Pharmacies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 126 Global Respiratory Drug Delivery Market for E-Commerce Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 127 Global Respiratory Drug Delivery Market for E-Commerce Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 128 Global Respiratory Drug Delivery Market for E-Commerce Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 129 Global Respiratory Drug Delivery Market for E-Commerce Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 130 Global Respiratory Drug Delivery Market for E-Commerce Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 131 Global Respiratory Drug Delivery Market Forecast by End-User, 2020-2030 (US$ billion, AGR %)
  • Figure 132 Global Respiratory Drug Delivery Market Share Forecast by End-User, 2020, 2025, 2030 (%)
  • Figure 133 Global Respiratory Drug Delivery Market for Hospitals & Clinics Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 134 Global Respiratory Drug Delivery Market for Hospitals & Clinics Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 135 Global Respiratory Drug Delivery Market for Hospitals & Clinics Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 136 Global Respiratory Drug Delivery Market for Hospitals & Clinics Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 137 Global Respiratory Drug Delivery Market for Hospitals & Clinics Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 138 Global Respiratory Drug Delivery Market for Homecare Settings Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 139 Global Respiratory Drug Delivery Market for Homecare Settings Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 140 Global Respiratory Drug Delivery Market for Homecare Settings Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 141 Global Respiratory Drug Delivery Market for Homecare Settings Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 142 Global Respiratory Drug Delivery Market for Homecare Settings Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 143 Global Respiratory Drug Delivery Market Forecast by Region 2020-2030 (US$ billion)
  • Figure 144 Global Respiratory Drug Delivery Market Share Forecast by Region 2020, 2025, 2030 (%)
  • Figure 145 Global Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 146 Global Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 147 Global Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 148 Global Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 149 North America Respiratory Drug Delivery Market Forecast by Country 2020-2030 (US$ billion)
  • Figure 150 North America Respiratory Drug Delivery Market Share Forecast by Country 2020, 2025, 2030 (%)
  • Figure 151 North America Respiratory Drug Delivery Market Forecast by Product, 2020-2030 (US$ billion, AGR%)
  • Figure 152 North America Respiratory Drug Delivery Market Forecast by Formulation, 2020-2030 (US$ billion, AGR%)
  • Figure 153 North America Respiratory Drug Delivery Market Forecast by Devices, 2020-2030 (US$ billion, AGR%)
  • Figure 154 North America Respiratory Drug Delivery Market Forecast by Nebulizers, 2020-2030 (US$ billion, AGR%)
  • Figure 155 North America Respiratory Drug Delivery Market Forecast by Canister Type, 2020-2030 (US$ billion, AGR%)
  • Figure 156 North America Respiratory Drug Delivery Market Forecast by Application, 2020-2030 (US$ billion, AGR%)
  • Figure 157 North America Respiratory Drug Delivery Market Forecast by Distribution Channel, 2020-2030 (US$ billion, AGR%)
  • Figure 158 North America Respiratory Drug Delivery Market Forecast by End-User, 2020-2030 (US$ billion, AGR%)
  • Figure 159 U.S. Respiratory Drug Delivery Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 160 U.S. Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 161 U.S. Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 162 U.S. Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 163 U.S. Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 164 Canada Respiratory Drug Delivery Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 165 Canada Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 166 Canada Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 167 Canada Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 168 Canada Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 169 Europe Respiratory Drug Delivery Market Forecast by Country 2020-2030 (US$ billion)
  • Figure 170 Europe Respiratory Drug Delivery Market Share Forecast by Country 2020, 2025, 2030 (%)
  • Figure 171 Europe Respiratory Drug Delivery Market Forecast by Product, 2020-2030 (US$ billion, AGR%)
  • Figure 172 Europe Respiratory Drug Delivery Market Forecast by Formulation, 2020-2030 (US$ billion, AGR%)
  • Figure 173 Europe Respiratory Drug Delivery Market Forecast by Devices, 2020-2030 (US$ billion, AGR%)
  • Figure 174 Europe Respiratory Drug Delivery Market Forecast by Nebulizers, 2020-2030 (US$ billion, AGR%)
  • Figure 175 Europe Respiratory Drug Delivery Market Forecast by Canister Type, 2020-2030 (US$ billion, AGR%)
  • Figure 176 Europe Respiratory Drug Delivery Market Forecast by Application, 2020-2030 (US$ billion, AGR%)
  • Figure 177 Europe Respiratory Drug Delivery Market Forecast by Distribution Channel, 2020-2030 (US$ billion, AGR%)
  • Figure 178 Europe Respiratory Drug Delivery Market Forecast by End-User, 2020-2030 (US$ billion, AGR%)
  • Figure 179 Germany Respiratory Drug Delivery Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 180 Germany Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 181 Germany Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 182 Germany Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 183 Germany Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 184 France Respiratory Drug Delivery Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 185 France Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 186 France Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 187 France Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 188 France Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 189 UK Respiratory Drug Delivery Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 190 UK Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 191 UK Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 192 UK Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 193 UK Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 194 Italy Respiratory Drug Delivery Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 195 Italy Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 196 Italy Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 197 Italy Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 198 Italy Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 199 Spain Respiratory Drug Delivery Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 200 Spain Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 201 Spain Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 202 Spain Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 203 Spain Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 204 Belgium Respiratory Drug Delivery Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 205 Belgium Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 206 Belgium Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 207 Belgium Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 208 Belgium Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 209 Switzerland Respiratory Drug Delivery Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 210 Switzerland Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 211 Switzerland Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 212 Switzerland Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 213 Switzerland Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 214 Rest of Europe Respiratory Drug Delivery Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 215 Rest of Europe Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 216 Rest of Europe Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 217 Rest of Europe Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 218 Rest of Europe Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 219 Asia Pacific Respiratory Drug Delivery Market Forecast by Country 2020-2030 (US$ billion)
  • Figure 220 Asia Pacific Respiratory Drug Delivery Market Share Forecast by Country 2020, 2025, 2030 (%)
  • Figure 221 Asia Pacific Respiratory Drug Delivery Market Forecast by Product, 2020-2030 (US$ billion, AGR%)
  • Figure 222 Asia Pacific Respiratory Drug Delivery Market Forecast by Formulation, 2020-2030 (US$ billion, AGR%)
  • Figure 223 Asia Pacific Respiratory Drug Delivery Market Forecast by Devices, 2020-2030 (US$ billion, AGR%)
  • Figure 224 Asia Pacific Respiratory Drug Delivery Market Forecast by Nebulizers, 2020-2030 (US$ billion, AGR%)
  • Figure 225 Asia Pacific Respiratory Drug Delivery Market Forecast by Canister Type, 2020-2030 (US$ billion, AGR%)
  • Figure 226 Asia Pacific Respiratory Drug Delivery Market Forecast by Application, 2020-2030 (US$ billion, AGR%)
  • Figure 227 Asia Pacific Respiratory Drug Delivery Market Forecast by Distribution Channel, 2020-2030 (US$ billion, AGR%)
  • Figure 228 Asia Pacific Respiratory Drug Delivery Market Forecast by End-User, 2020-2030 (US$ billion, AGR%)
  • Figure 229 Japan Respiratory Drug Delivery Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 230 Japan Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 231 Japan Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 232 Japan Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 233 Japan Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 234 China Respiratory Drug Delivery Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 235 China Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 236 China Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 237 China Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 238 China Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 239 India Respiratory Drug Delivery Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 240 India Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 241 India Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 242 India Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 243 India Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 244 Australia Respiratory Drug Delivery Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 245 Australia Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 246 Australia Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 247 Australia Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 248 Australia Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 249 Malaysia Respiratory Drug Delivery Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 250 Malaysia Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 251 Malaysia Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 252 Malaysia Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 253 Malaysia Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 254 Rest of Asia Pacific Respiratory Drug Delivery Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 255 Rest of Asia Pacific Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 256 Rest of Asia Pacific Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 257 Rest of Asia Pacific Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 258 Rest of Asia Pacific Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 259 Latin America Respiratory Drug Delivery Market Forecast by Country 2020-2030 (US$ billion)
  • Figure 260 Latin America Respiratory Drug Delivery Market Share Forecast by Country 2020, 2025, 2030 (%)
  • Figure 261 Latin America Respiratory Drug Delivery Market Forecast by Product, 2020-2030 (US$ billion, AGR%)
  • Figure 262 Latin America Respiratory Drug Delivery Market Forecast by Formulation, 2020-2030 (US$ billion, AGR%)
  • Figure 263 Latin America Respiratory Drug Delivery Market Forecast by Devices, 2020-2030 (US$ billion, AGR%)
  • Figure 264 Latin America Respiratory Drug Delivery Market Forecast by Nebulizers, 2020-2030 (US$ billion, AGR%)
  • Figure 265 Latin America Respiratory Drug Delivery Market Forecast by Canister Type, 2020-2030 (US$ billion, AGR%)
  • Figure 266 Latin America Respiratory Drug Delivery Market Forecast by Application, 2020-2030 (US$ billion, AGR%)
  • Figure 267 Latin America Respiratory Drug Delivery Market Forecast by Distribution Channel, 2020-2030 (US$ billion, AGR%)
  • Figure 268 Latin America Respiratory Drug Delivery Market Forecast by End-User, 2020-2030 (US$ billion, AGR%)
  • Figure 269 Brazil Respiratory Drug Delivery Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 270 Brazil Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 271 Brazil Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 272 Brazil Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 273 Brazil Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 274 Mexico Respiratory Drug Delivery Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 275 Mexico Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 276 Mexico Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 277 Mexico Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 278 Mexico Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 279 Argentina Respiratory Drug Delivery Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 280 Argentina Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 281 Argentina Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 282 Argentina Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 283 Argentina Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 284 Rest of Latin America Respiratory Drug Delivery Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 285 Rest of Latin America Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 286 Rest of Latin America Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 287 Rest of Latin America Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 288 Rest of Latin America Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 289 Middle East and Africa Respiratory Drug Delivery Market Forecast by Country 2020-2030 (US$ billion)
  • Figure 290 Middle East and Africa Respiratory Drug Delivery Market Share Forecast by Country 2020, 2025, 2030 (%)
  • Figure 291 Middle East and Africa Respiratory Drug Delivery Market Forecast by Product, 2020-2030 (US$ billion, AGR%)
  • Figure 292 Middle East and Africa Respiratory Drug Delivery Market Forecast by Formulation, 2020-2030 (US$ billion, AGR%)
  • Figure 293 Middle East and Africa Respiratory Drug Delivery Market Forecast by Devices, 2020-2030 (US$ billion, AGR%)
  • Figure 294 Middle East and Africa Respiratory Drug Delivery Market Forecast by Nebulizers, 2020-2030 (US$ billion, AGR%)
  • Figure 295 Middle East and Africa Respiratory Drug Delivery Market Forecast by Canister Type, 2020-2030 (US$ billion, AGR%)
  • Figure 296 Middle East and Africa Respiratory Drug Delivery Market Forecast by Application, 2020-2030 (US$ billion, AGR%)
  • Figure 297 Middle East and Africa Respiratory Drug Delivery Market Forecast by Distribution Channel, 2020-2030 (US$ billion, AGR%)
  • Figure 298 Middle East and Africa Respiratory Drug Delivery Market Forecast by End-User, 2020-2030 (US$ billion, AGR%)
  • Figure 299 GCC Respiratory Drug Delivery Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 300 GCC Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 301 GCC Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 302 GCC Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 303 GCC Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 304 South Africa Respiratory Drug Delivery Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 305 South Africa Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 306 South Africa Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 307 South Africa Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 308 South Africa Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 309 Rest of Middle East and Africa Respiratory Drug Delivery Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 310 Rest of Middle East and Africa Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "V" Shaped Recovery
  • Figure 311 Rest of Middle East and Africa Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "U" Shaped Recovery
  • Figure 312 Rest of Middle East and Africa Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "W" Shaped Recovery
  • Figure 313 Rest of Middle East and Africa Respiratory Drug Delivery Market Forecast, 2020-2030 (US$ billion, AGR%): "L" Shaped Recovery
  • Figure 314 GlaxoSmithKline plc : Net Revenue, 2015-2019 (US$ Mn, AGR%)
  • Figure 315 GlaxoSmithKline plc : EBIDTA, 2015-2019 (US$ Mn, AGR%)
  • Figure 316 GlaxoSmithKline plc : Gross Profit, 2015-2019 (US$ Mn, AGR%)
  • Figure 317 Respironics, Inc. : Net Revenue, 2015-2019 (US$ Mn, AGR%)
  • Figure 318 Respironics, Inc. : EBIDTA, 2015-2019 (US$ Mn, AGR%)
  • Figure 319 Respironics, Inc. : Gross Profit, 2015-2019 (US$ Mn, AGR%)
  • Figure 320 Boehringer Ingelheim : Net Revenue, 2015-2019 (US$ Mn, AGR%)
  • Figure 321 3M : Net Revenue, 2015-2019 (US$ Mn, AGR%)
  • Figure 322 3M : EBIDTA, 2015-2019 (US$ Mn, AGR%)
  • Figure 323 3M : Gross Profit, 2015-2019 (US$ Mn, AGR%)
  • Figure 324 AstraZeneca : Net Revenue, 2015-2019 (US$ Mn, AGR%)
  • Figure 325 AstraZeneca : EBIDTA, 2015-2019 (US$ Mn, AGR%)
  • Figure 326 AstraZeneca : Gross Profit, 2015-2019 (US$ Mn, AGR%)
  • Figure 327 Merck & Co., Inc. : Net Revenue, 2015-2019 (US$ Mn, AGR%)
  • Figure 328 Merck & Co., Inc. : EBIDTA, 2015-2019 (US$ Mn, AGR%)
  • Figure 329 Merck & Co., Inc. : Gross Profit, 2015-2019 (US$ Mn, AGR%)
  • Figure 330 Novartis AG : Net Revenue, 2015-2019 (US$ Mn, AGR%)
  • Figure 331 Novartis AG : EBIDTA, 2015-2019 (US$ Mn, AGR%)
  • Figure 332 Novartis AG : Gross Profit, 2015-2019 (US$ Mn, AGR%)
  • Figure 333 OMRON Corporation : Net Revenue, 2015-2019 (US$ Mn, AGR%)
  • Figure 334 OMRON Corporation : EBIDTA, 2015-2019 (US$ Mn, AGR%)
  • Figure 335 OMRON Corporation : Gross Profit, 2015-2019 (US$ Mn, AGR%)
  • Figure 336 Sunovion Pharmaceuticals Inc. : Net Revenue, 2015-2019 (US$ Mn, AGR%)
  • Figure 337 Sunovion Pharmaceuticals Inc. : EBIDTA, 2015-2019 (US$ Mn, AGR%)
  • Figure 338 Sunovion Pharmaceuticals Inc. : Gross Profit, 2015-2019 (US$ Mn, AGR%)
  • Figure 339 Teva Pharmaceutical : Net Revenue, 2015-2019 (US$ Mn, AGR%)
  • Figure 340 Teva Pharmaceutical : EBIDTA, 2015-2019 (US$ Mn, AGR%)
  • Figure 341 Teva Pharmaceutical : Gross Profit, 2015-2019 (US$ Mn, AGR%)
  • Figure 342 F. Hoffmann-La Roche Ltd. : Net Revenue, 2015-2019 (US$ Mn, AGR%)
  • Figure 343 F. Hoffmann-La Roche Ltd. : EBIDTA, 2015-2019 (US$ Mn, AGR%)
  • Figure 344 F. Hoffmann-La Roche Ltd. : Gross Profit, 2015-2019 (US$ Mn, AGR%)
  • Figure 345 Cipla : Net Revenue, 2017-2019 (US$ Mn, AGR%)
  • Figure 346 Cipla : EBIDTA, 2015-2019 (US$ Mn, AGR%)
  • Figure 347 Cipla : Gross Profit, 2015-2019 (US$ Mn, AGR%)
  • Figure 348 Pulmatrix : Net Revenue, 2015-2019 (US$ Mn, AGR%)
  • Figure 349 Pulmatrix : EBIDTA, 2015-2019 (US$ Mn, AGR%)
  • Figure 350 Pulmatrix : Gross Profit, 2015-2019 (US$ Mn, AGR%)
  • Figure 351 Regeneron Pharmaceuticals, Inc. : Net Revenue, 2015-2019 (US$ Mn, AGR%)
  • Figure 352 Regeneron Pharmaceuticals, Inc. : EBIDTA, 2015-2019 (US$ Mn, AGR%)
  • Figure 353 Regeneron Pharmaceuticals, Inc. : Gross Profit, 2015-2019 (US$ Mn, AGR%)
  • Figure 354 Grifols, S.A. : Net Revenue, 2015-2019 (US$ Mn, AGR%)
  • Figure 355 Grifols, S.A. : EBIDTA, 2015-2019 (US$ Mn, AGR%)
  • Figure 356 Grifols, S.A. : Gross Profit, 2015-2019 (US$ Mn, AGR%)
  • Figure 357 Innoviva : Net Revenue, 2015-2019 (US$ Mn, AGR%)
  • Figure 358 Innoviva : EBIDTA, 2015-2019 (US$ Mn, AGR%)
  • Figure 359 Innoviva : Gross Profit, 2015-2019 (US$ Mn, AGR%)

Companies Profiled in the Report:

  • 3M
  • AstraZeneca
  • Boehringer Ingelheim
  • Cipla
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline plc
  • Grifols, S.A.
  • Innoviva
  • Merck & Co., Inc.
  • Novartis AG
  • OMRON Corporation
  • Pulmatrix
  • Regeneron Pharmaceuticals, Inc.
  • Respiratorius AB
  • Respironics, Inc.
  • Sunovion Pharmaceuticals Inc.
  • Teva Pharmaceutical

List of Other Companies:

  • ALK-Abello A/S
  • Amphastar Pharmaceuticals, Inc.
  • Aphios
  • AptarGroup, Inc.
  • BeyonDevices
  • Chiesi Farmaceutici
  • Dermira Inc.
  • GF Health Products, Inc.
  • Glenmark
  • Monitored Therapeutics, Inc. (MTI)
  • MundiPharma
  • Mylan
  • Progressive Trade Media Limited
  • Pulmatrix
  • Sandoz
  • Sanofi
  • Sepracor Inc.
  • Sorrento
  • Theravance Biopharma-Mylan Inc.
  • Torii
  • Vectura Group plc
  • Verona Pharma plc

List of Organizations:

  • American College of Chest Physicians
  • American Thoracic Society
  • British Lung Foundation
  • Centers for Disease Control and Prevention
  • European Databank on Medical Devices
  • European Respiratory Society
  • Food and Drug Administration
  • German Ministry of Health
  • Global Initiative for Asthma
  • Global Initiative for Chronic Obstructive Lung Disease
  • Journal of COPD Foundation
  • Ministry of Health, Labour and Welfare
  • National Heart and Lung Institute
  • Royal College of Physicians
  • UK NHS
  • World Health Organization (WHO)